Navigation Links
Pharma ChemOutsourcing Targets BioNJ, PA Bio, MassBio, BayBio, SoCalBio, and NY Biotechnology Association Member Companies for September 2011 Show in New Jersey
Date:3/1/2011

LONG BRANCH, N.J., March 1, 2011 /PRNewswire/ -- Pharma ChemOutsourcing today announced that it would offer a special rate to select member companies of the USA's various state biotechnology associations to help make the event financially accessible to all those who would like to attend the September 12-15 show in New Jersey.

"We have all witnessed the explosive growth of hundreds of successful biotechnology companies over the past 12 years. Many of them already attend or speak at Pharma ChemOutsourcing's annual event and many more would benefit. This year we want to be sure that everyone knows about the opportunity and takes advantage of it. So we have implemented a special rate until May 15, 2011 to make it possible," remarked Mark Alexay, Pharma ChemOutsourcing's President. Details may be found at http://chemoutsourcing.com/biotech.php

"The biotech attendees return to the show year after year, tell us it's a great place to network, talk about chemistry, and meet their suppliers. Our goal is to continue to mold the show into a special annual event for pharmaceutical chemists. With biotech's ascending role in the discovery and development of new therapeutics, now is the time to further tailor the show to meet their changing needs." The list of the first 50 biotech speakers for the September 12-15, 2011 show is at http://chemoutsourcing.com/speakers.php

"Our ultimate goal is to attract chemists from every emerging and medium-sized pharmaceutical company in the world – The USA is the world leader in biotechnology – so facilitating quality interactions among its leader at the event is good for business. Pharma ChemOutsourcing's niche is for R&D management. We bring together large numbers of medicinal and process chemists, plus chemical development. In 2010 we attracted about 800 attendees. The value of the show will grow if
'/>"/>

SOURCE Pharma ChemOutsourcing
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Solutions, Inc. (NASDAQ: BLFS ), a leading developer, manufacturer ... and cryopreservation freeze media and precision thermal ... "Company"), announced that the Company is scheduled to present at ... is scheduled to present at the Conference at 1:30 p.m. ... Hotel in New York City and ...
(Date:5/22/2015)... FORT WORTH, Texas , May 22, 2015 ... at $58.4 million in 2014 and is estimated to reach ... 2014 to 2019. Browse through the TOC of ... trends and segments, with the help of various tables and ... buyers will receive 10% customization on this report.   ...
(Date:5/22/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... the results of the Company,s 72-patient, placebo-controlled Phase ... for the treatment of dry eye patients using ... model.  The exploratory study was completed in late ... by the Company in a press release, identify ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4
... 2 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin ... developer, manufacturer and supplier of pharmaceutical products and ... conditions, today announced it has received a patent ... Aoxing Ganbao product. The patent number is 551073. ...
... NEW YORK, Oct. 1 Intercept Pharmaceuticals, Inc., has ... INT-747 has met the primary endpoint of improved insulin ... trial in type 2 diabetic patients with nonalcoholic fatty ... clamp procedure, the study demonstrated that a single oral ...
Cached Medicine Technology:Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao 2Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao 3Intercept Pharmaceuticals' FXR Agonist INT-747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease 2
(Date:5/22/2015)... 2015 Coordinating care for people ... Historically providers have not been reimbursed or rewarded ... 2015, Medicare has paved the way by offering ... the launch of Oculus Health , an ... using the platform will now be able to ...
(Date:5/22/2015)... According to a new Aegis Living Study on ... likely to worry about what will happen to their memory ... 69% Silent Generation), which may help explain why nearly half ... particularly Millennials (47%), Gen X’ers (51%), and Boomers (43%). The ... among more than 2,000 U.S. adults ages 18+. , ...
(Date:5/22/2015)... May 22, 2015 Coco Libre, the Official ... RecordSetter.com World Record at the 104th running of the race. ... ice luge served 315 people in one hour—one person about ... race is so true to the heart of the Bay ... an ice luge to the finish line only made sense,” ...
(Date:5/22/2015)... 2015 According to Berks and Beyond ... related death, totaling almost 2,500 confirmed drug deaths, as reported ... officials, totals 2,489 deaths stemming from legal and illegal drug ... seven people every day to fatal overdoses or other drug ... as one of the most rife with drug related deaths. ...
(Date:5/22/2015)... May 22, 2015 Gateway Building Concepts ... renovations. The services the company specialize in include decks, ... basements, pool houses and much more. , The ... the owner of the company. It includes two geometrical ... design was thought out to be used with many ...
Breaking Medicine News(10 mins):Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Coco Libre Ice Luge Sets New World Record at Bay to Breakers 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2
... But glucose-based beverages may not have same impact, study ... soft drinks and other beverages can have a negative ... ability to handle fats, increasing the risk of heart ... But glucose-sweetened beverages don,t have that kind of impact, ...
... advantages, limits of procedure, study suggests , , MONDAY, April ... for removal of certain head and neck cancers, U.S. ... oral cavity, throat or larynx tumors. Of those patients, ... the cancerous tissue. Negative margins (when no cancer cells ...
... early clinical trial, researchers at the University of Chicago ... grapefruit juice with the drug rapamycin can increase drug ... given. They also showed that the combination can be ... For two decades, pharmacists have pasted DO-NOT-TAKE-WITH-GRAPEFRUIT-JUICE stickers on ...
... healthy choices these days, so why do Americans, waistlines continue ... Consumer Research shows that some efforts to control eating ... healthy eating goal even if they choose an unhealthy food, ... may draw their attention to the least-healthy choice available, according ...
... Make Professional Skin Care Accessible to EveryoneCARLSBAD, Calif., April 20 ... picking up the kids, managing a career and household, and ... the money, she deserves a break and, even in these ... present the best image possible."In a time like this, it,s ...
... April 20 Mylan Inc. (Nasdaq: MYL ) ... live webcast on Thursday, April 30, 2009, at 10:00 a.m. ... quarter 2009, which ended March 31, 2009. Mylan will ... opens.The dial-in number to access the April 30 call is ...
Cached Medicine News:Health News:Robotic Surgery Practical for Some Head, Neck Tumors 2Health News:Grapefruit juice boosts drug's anti-cancer effects 2Health News:Grapefruit juice boosts drug's anti-cancer effects 3Health News:Best intentions: The presence of healthy food can lead to unhealthy choices 2Health News:She Works Hard for the Money, so She Shouldn't Have to Work Hard for Great Skin 2Health News:She Works Hard for the Money, so She Shouldn't Have to Work Hard for Great Skin 3
The Astigmatome makes precise and accurate cuts for astigmatism correction simply and safely. The procedure can be done in the office under topical anesthesia. Complete Set Includes Vacuum Speculum, ...
... of temporary sensing and pacing leads. Our ... temporary pacing leads and improved upon the ... and less traumatic to heart tissue. , ... to provide consistent temporary sensing and pacing ...
... indication for this technique is acquired ... Indications for tricuspid repair are based ... as diagnosed by angiography and dye ... In patients with an irreversible tricuspid ...
... Pro Medical Billing proudly offers distinct ... your area of expertise. ... diagnosis codes and medical records templates ... practice, ob/gyn, sports medicine, ophthalmology, allergy, ...
Medicine Products: